Indeed, genetic manipulation of neurotrophic factor expression, such as nerve growth factor (NGF) or glial-derived neurotrophic factor (GDNF) overexpression, have shown success in experimental models of clinical diseases including stroke [12, 13]. The gene discussed is NGF; the disease is stroke disorder.